isradipin treatment hypertens addit effect one-year studi placebo run-in phase week durat mg mg isradipin year patient hypertens good control blood pressur major patient third month treatment month necessari beta-block treatment regimen patient order target blood pressur mm Hg patient exercise-test bicycl ergometri month diastol blood pressur exercis treatment valu end placebo run-in baselin valu valu systol blood pressur treatment baselin result decreas peripher vascular resist isradipin year result administr beta-block bopindolol sandonorm sandoz pharma basl switzerland total cholesterol high-dens lipoprotein cholesterol level treatment triglycerid month year averag valu normal rang influenc isradipin plasma renin activ pra aldosteron level valu rest exercis pra first month level aldosteron level month subsequ decreas result diltiazem similar treatment regimen 